The US Food and Drug Administration (FDA) is to conduct reviews into the abortion drug mifepristone, infant formula, and talc, while health secretary Robert F Kennedy Jr expressed support for broader ...

Kennedy said in an op-ed Monday that all 17 members of the Advisory Committee on Immunization Practices with be 'retired.' ...

How are we going to implement these things…[when] you can’t even say the words ‘disparity,’ ‘inequity,’ ‘women,’ ‘race’?” ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

Here’s a look at the complex early history of abortion in the United States. There weren't any laws against abortion in the U.S. until the 19th century—and as those laws grew more restrictive ...

The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...

California, Massachusetts, New York and New Jersey petitioned the U.S. Food and Drug Administration on Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's proven ...

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug ...

The attorneys general of New York, California, Massachusetts and New Jersey asked the Food and Drug Administration to expand ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...